Leerink Partners Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Michael Cherny maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $14 to $10.
Leerink Partners analyst Michael Cherny maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $14 to $10.